ÂÜÀòÂÒÂ×

Mark Conley is a seasoned finance professional with extensive experience in biopharmaceutical and healthcare sectors. Currently, Mark serves as the VP of Finance at SAb Biotherapeutics, following a role as Chief Financial Officer at Radius Health, Inc. Mark's previous positions include VP of Finance at Kaleido Biosciences and VP Corporate Controller/Treasurer at Valeritas, where responsibilities encompassed accounting, financial reporting, planning, analysis, internal controls, and cash management. Mark also held interim CFO positions and strategic roles at Eastern Research Group and Thermo Fisher Scientific, overseeing global finance activities. An educational background includes an MBA in Finance from Bryant University and a BSBA in Accounting from Oklahoma State University.